PronoKal

PronoKal Group is a global healthcare company specializing in medically supervised weight management and personalized medical nutrition. The company is best known for its proprietary PronoKal Method, a protein-rich ketogenic diet protocol designed to treat obesity and overweight through a multidisciplinary approach involving medical supervision, nutritional coaching, and physical activity. Following its acquisition by Nestlé Health Science in 2022, the company continues to expand its evidence-based digital health and nutritional solutions across Europe and Latin America. PronoKal emphasizes scientific research and clinical validation for its metabolic health programs, positioning itself as a leader in the medical nutrition space.